Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
8/16/2024
Huadong Secures Asia Rights to Two South Korean Autoimmune Disease Dru...
8/16/2024
Recent Official and Executive Moves
8/15/2024
Akeso's sNDA for Ivonescimab (PD-1/VEGF) Granted Priority Review in Ch...
8/15/2024
SAMR Releases Draft Pharma Anti-monopoly Guidelines
8/15/2024
China Introduces Guidelines to Encourage Development of 'Digital, Smar...
8/15/2024
Patent Term Compensation: New Policy Interpretation And Operation Guid...
8/14/2024
China Biopharma Tracker – July 2024 (PharmaDJ)
8/14/2024
Apollomics Announces Positive Preliminary Data of Vebreltinib
8/13/2024
OcuMension Acquires China Rights to Alcon Eye Drops with 16.7% Equity ...
8/13/2024
MNC Pharma Companies in China Return to Growth after Years of VBP Turb...
8/13/2024
Junshi's sNDA for Toripalimab as First-Line Treatment of Unresectable/...
8/9/2024
Sable Thera Announces Worldwide Licensing Deal with Columbia Univers...
8/9/2024
Merck to Acquire Investigational B-Cell Depletion Therapy from Curon
8/9/2024
Cullinan Returns Bispecific to Harbour BioMed One Year After Paying $2...
8/9/2024
WuXi, Medigene Team Up for T Cell-activating Cancer Therapies
8/9/2024
Recent Executive Moves
8/8/2024
WestGene Secures Dual IND Approvals for mRNA Cancer Vaccine Targeting ...
8/7/2024
NHSA Publicizes the List of Drugs Passing Preliminary Form Evaluation ...
8/7/2024
A Share-listed Biopharma Cos Saw Positive Trends in H1/2024 with Incre...
8/7/2024
Uncertainty Looms Over Gardasil's Future in China
8/6/2024
Organon Reports Falling China Sales in Q2/2024 Impacted by VBP
8/6/2024
Asymchem Inaugurates New Site in Sandwich, UK
8/6/2024
Huadong to Pay $150M for Right to Market ImunoPharm's Novel Anticance...
8/6/2024
NHSA's 2023 National BMI Sector Development Report (Thorough Summary)
8/6/2024
Buyout of China's Drug Companies by Global Pharma Giants Sparks Nation...
8/5/2024
Association of Lifestyle with Sleep Health In General Population in Ch...
8/5/2024
Snapshot of BMI System Financial Performance in H1/2024
8/5/2024
Genmab Assumes Full Ownership of Acasunlimab after BioNTech Exits Part...
8/5/2024
China Deepens Medical Reform through "Health-first Strategy
8/2/2024
Kyowa Kirin Restructures Asia-Pacific Operations, Sells China Business...
Page:
21
/
354
Total number of articles:
10618
:
[First]
[<<]
[19]
[20]
[21]
[22]
[23]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit